CervoMed Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q1 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CervoMed Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q1 2025.
  • CervoMed Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 14, 2025 was 8.7M shares, a 41% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 8.7M +2.53M +41% Mar 14, 2025 10-K 2025-03-17
Q3 2024 8.25M +2.58M +45.5% Nov 7, 2024 10-Q 2024-11-12
Q2 2024 8.25M +6.21M +305% Aug 8, 2024 10-Q 2024-08-09
Q1 2024 6.17M +4.13M +202% Mar 26, 2024 10-K 2024-03-29
Q3 2023 5.67M +3.64M +178% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 2.04M +1.17K +0.06% Aug 7, 2023 10-Q 2023-08-08
Q1 2023 2.04M -99.9M -98% Mar 15, 2023 10-K 2023-03-24
Q3 2022 2.04M -99.9M -98% Nov 14, 2022 10-Q 2022-11-14
Q2 2022 2.04M -99.9M -98% Aug 10, 2022 10-Q 2022-08-12
Q1 2022 102M +20.6K +0.02% Mar 14, 2022 10-K 2022-03-18
Q3 2021 102M +37.9M +59.2% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 102M +37.9M +59.2% Aug 11, 2021 10-Q 2021-08-11
Q1 2021 102M +67.3M +194% Mar 12, 2021 10-K 2021-03-17
Q3 2020 64M +59.3M +1264% Nov 11, 2020 10-Q 2020-11-12
Q2 2020 64M +59.3M +1264% Aug 5, 2020 10-Q 2020-08-07
Q1 2020 34.6M +31.2M +924% Mar 12, 2020 10-K 2020-03-17
Q3 2019 4.69M -46M -90.7% Nov 6, 2019 10-Q 2019-11-08
Q2 2019 4.69M -45.9M -90.7% Aug 8, 2019 10-Q 2019-08-08
Q1 2019 3.38M -47.1M -93.3% Mar 13, 2019 10-K 2019-03-19
Q3 2018 50.6M +36.1M +249% Nov 1, 2018 10-Q 2018-11-13
Q2 2018 50.6M +36.5M +261% Aug 9, 2018 10-Q 2018-08-10
Q1 2018 50.5M +40.2M +388% Mar 13, 2018 10-K 2018-04-02
Q3 2017 14.5M +4.18M +40.4% Nov 10, 2017 10-Q 2017-11-13
Q2 2017 14M -88.4M -86.3% Aug 11, 2017 10-Q 2017-08-14
Q1 2017 10.3M -91.2M -89.8% Mar 15, 2017 10-K 2017-03-31
Q3 2016 10.3M -8.27M -44.4% Oct 31, 2016 10-Q 2016-11-14
Q2 2016 102M +83.8M +450% May 16, 2016 10-Q 2016-05-16
Q1 2016 102M +83M +446% Mar 21, 2016 10-K 2016-03-25
Q3 2015 18.6M +9.34K +0.05% Nov 10, 2015 10-Q 2015-11-12
Q2 2015 18.6M +147K +0.8% Aug 12, 2015 10-Q 2015-08-12
Q1 2015 18.6M +9.93M +114% Mar 25, 2015 10-K 2015-04-03
Q3 2014 18.6M -407M -95.6% Nov 10, 2014 10-Q 2014-11-12
Q2 2014 18.5M -403M -95.6% Aug 11, 2014 10-Q 2014-08-14
Q1 2014 8.68M -81.8M -90.4% Apr 1, 2014 10-K/A 2014-04-23
Q3 2013 426M Nov 11, 2013 10-Q 2013-11-19
Q2 2013 421M +332M +371% Aug 13, 2013 10-Q 2013-08-14
Q1 2013 90.5M +2.32M +2.63% Apr 15, 2013 10-K/A 2013-04-24
Q4 2012 90.5M +10.3M +12.9% Nov 16, 2012 10-Q 2012-11-19
Q2 2012 89.4M Aug 14, 2012 10-Q/A 2012-09-07
Q1 2012 88.2M May 15, 2012 10-K 2012-05-21
Q4 2011 80.1M Nov 15, 2011 10-Q 2011-11-21
Q3 2011 77.5M Aug 15, 2011 10-Q 2011-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.